U.S. federal trademark · Serial No. 88564436
T-cell pharmaceutical products for the treatment of cancer; therapeutic targets, namely, proteins or protein complexes, for the treatment and prevention of cancer; therapeutic cells, for medical use, for the treatment and prevention of cancer; therapeutic proteins and therapeutic antibodies, for medical use, for the treatment and prevention of cancer in humans; therapeutics and cellular therapies in the nature of proteins and protein complexes for the treatment of cancer; biologics, namely, proteins and protein complexes, for in-vitro diagnostic use for the treatment of cancer
Provision of, and identification and development of, therapeutic targets, namely, proteins and protein complexes, for others for the treatment and prevention of cancer; development of therapeutics and cellular therapies, namely, pharmaceutical, biological and medical therapies for the treatment of cancer; biotechnology research, development, testing and analysis for the treatment of cancer; scientific research and development services; providing scientific information in the fields of treatment and prevention of cancer
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.